| Literature DB >> 30240677 |
Richard D deShazo1, Sara B Parker2, Daniel Williams3, John B Ingram4, Mahmoud Elsohly5, Kathryn Rodenmeyer6, Kyle McCullouch7.
Abstract
The recent US Food and Drug Administration approval of the marijuana constituent cannabidiol as safe and effective for treatment of 2 rare forms of epilepsy has raised hopes that others of the 500 chemicals in marijuana will be found to be therapeutic. However, the long-term consequences of street marijuana use are unclear, and recent studies raise red flags about its effects. Changes in brain maturation and intellectual function, including decreases in intelligence quotient, have been noted in chronic users and appear permanent in early users in most but not all studies. These studies suggest that at a minimum, regular marijuana use should be discouraged in individuals under the age of 21.Entities:
Keywords: Adolescents; Brain development; Marijuana; Teenager
Year: 2018 PMID: 30240677 DOI: 10.1016/j.amjmed.2018.09.006
Source DB: PubMed Journal: Am J Med ISSN: 0002-9343 Impact factor: 4.965